The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement ...

Sackler family, who owned pharmaceutical company Purdue Pharma, will no longer be in control of the company or permitted to sell opioids if the new settlement plan is approved ...

A $7.4 billion settlement has been reached in principle between states, victims, and members of the Sackler family and Purdue ...

The Sackler family and Purdue Pharma have agreed to a $7.4 billion settlement to resolve federal claims brought by attorneys general from 15 states. Announced by New York Attorney General Letitia ...

The individuals behind Purdue Pharma's involvement in the U.S. opioid crisis reached a $7-billion settlement in January 2025.

Not every state has signed on yet. Under the new proposal, members of the Sackler family would also give up ownership of Purdue. They've already stepped down from the company's board and have ...

If one is not reached, it could open the floodgates to lawsuits against Sackler family members.The new settlement could bring to a close a chapter in a long legal saga over the toll of an opioid ...

Jan. 23 (UPI) --The Sackler family and Purdue Pharma have agreed to pay a $7.4 billion settlement to end federal court claims filed by attorneys general on behalf of 15 states. New York Attorney ...

Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running legal saga involving the pain medication Oxycontin and its role in ...